Single-arm, open-label study offers proof of concept for MSC-NTF cells
Phase 2 clinical study supports safety and efficacy of MSC-NTFs
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy